A novel JAK inhibitor JTE‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 27, Iss. 1, 2018-01 ,pp. : 22-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulation of Inflammatory Cytokine Production by MKP‐5 in Macrophages

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 2, 2015-08 ,pp. : 96-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel apoE-Derived Therapeutic Reduces Vasospasm and Improves Outcome in a Murine Model of Subarachnoid Hemorrhage

By Gao Junling   Wang Haichen   Sheng Huaxin   Lynch John R.   Warner David S.   Durham Lori   Vitek Michael P.   Laskowitz Daniel T.  

Neurocritical Care, Vol. 4, Iss. 1, 2006-02 ,pp. : 25-31

Humana Press, Inc

Access to resources Recommend Favorite

GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

By Pillai Lakshmi   Burnett Bruce P.   Levy Robert M.    

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1055-1063

Informa Healthcare

Access to resources Recommend Favorite

Synergism in survival to endotoxic shock in rats given microencapsulated CNI-1493 and antisense oligomers to NF-κB

By Oettinger Carl W.   D'Souza Martin J.  

Journal of Microencapsulation, Vol. 27, Iss. 4, 2010-02 ,pp. : 372-376

Informa Healthcare

Access to resources Recommend Favorite